iHumanIH +3.91%50 3-Year RORE % is -11.49 as of Mar. 2026. GuruFocus rates IH with a GF Score™ of 50/100 and a GF Value™ of $2.93 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 236 Education companies, iHuman ranks worse than 69.07% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
iHuman's 3-Year RORE % for the quarter that ended in Mar. 2026 was -11.49%.
The industry rank for iHuman's 3-Year RORE % or its related term are showing as below:
IH's 3-Year RORE % is ranked worse than 69.07% of 236
companies
in the Education industry
Industry Median: 7.445
vs IH: -11.49
iHuman (NYSE:IH) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
iHuman 3-Year RORE % Related Terms
iHuman 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for iHuman's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Education & Training Services subindustry, iHuman's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iHuman 3-Year RORE % vs Education Industry
For the Education industry and Consumer Defensive sector, iHuman's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where iHuman's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
iHuman (IH) has a 3-Year RORE % of -11.49 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on iHuman and its competitors. According to the industry distribution chart, iHuman ranks #163 out of 236 companies in the Education industry, placing it in the top 69.1%.
Is iHuman's 3-Year RORE % too high?
iHuman's current 3-Year RORE % is -11.49. Based on the distribution chart, iHuman ranks #163 out of 236 companies in the Education industry, which is below the industry midpoint. Overall, iHuman has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iHuman's 3-Year RORE % compare to STG and SKIL?
According to the Education industry distribution chart, iHuman ranks #163 out of 236 companies for 3-Year RORE %. This places iHuman in the lower half of its industry. The industry median 3-Year RORE % is 7.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Education company?
The median 3-Year RORE % among Education companies is 7.45, based on 236 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on iHuman and its competitors. For the Education industry, the median 3-Year RORE % is 7.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iHuman's current 3-Year RORE % is -11.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iHuman stock overvalued right now?
Based on GuruFocus' analysis, iHuman (IH) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.93, compared to a current price of $1.46 — trading 50.2% below its estimated fair value. The current 3-Year RORE % is -11.49. iHuman's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For iHuman (IH), the current 3-Year RORE % is -11.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iHuman (IH) Overvalued in 2026?
Based on GuruFocus' analysis, iHuman stock appears to be undervalued.
The current stock price of $1.46 is trading 50.2% below its estimated GF Value™ of $2.93.
GuruFocus considers iHuman to be Significantly Undervalued.
Key valuation signals for IH:
3-Year RORE %: -11.49
GF Value™: $2.93 vs. price of $1.46 (50.2% below fair value)
No single metric tells the full story. See the IH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.
50GF Score
Get the complete analysis for IH
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IH has been successfully added to your 
